DFP Healthcare Acquisitions Corp.

DFP Healthcare Acquisitions Corp.

DFPHU
DFP Healthcare Acquisitions Corp.US flagNASDAQ Global Select
10.26
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Steven I. Hochberg CPA, CPA,
Sector
Financial Services
Industry
Shell Companies
Address
780 Third Avenue New York City NY United States of America 10010
IPO Date
Mar 11, 2020
Business
DFP Healthcare Acquisitions Corp. (DFPHU) is a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in the healthcare industry encompassing services, therapeutics, devices, diagnostics, and animal health; it does not currently have significant independent operations or generate revenue. Incorporated in 2019 and headquartered in New York, New York, the company raised $230 million in its initial public offering in March 2020, with units trading under the ticker DFPHU on the OTC market, sponsored by an affiliate of Deerfield Management Company, L.P., a healthcare-focused investment firm, and healthcare executive Richard Barasch. In a major development completed on November 12, 2021, DFP Healthcare Acquisitions Corp. merged with The Oncology Institute, Inc., in a reverse merger transaction valuing the combined entity at approximately $842 million on a pro forma enterprise basis, after which the surviving company, renamed The Oncology Institute, began trading on Nasdaq under new tickers (TOI); the deal included a $275 million PIPE investment from healthcare investors such as Fidelity Management & Research Company LLC, Deerfield Management, and Redmile Group, LLC, to fuel expansion in value-based oncology care services across the U.S. As of late 2025, DFP Healthcare Acquisitions Corp. units (DFPHU) continue to trade on the OTC market with low volume and a market capitalization around $38.5 million, amid indications of potential delisting and no further disclosed business combinations or operational shifts since the 2021 merger.

Company News

APIChatGPT